[lollobomb]

It is so sad that there are so many vultures eager to make a profit out of desperate people with terrible diseases. This is why ethical guidelines and FDA regulations are for, after all. Of course it would be great to judge case-by-case (the scientist in the article is a real hero!). I would like to see a detailed cost-to-benefit study on the topic of allowing unapproved treatments for terminally ill patients.

[chriskanan]

On the flip side, potentially very good treatments that can't be patented or won't yield a good profit margin are not explored because it is very expensive and time consuming to get approval for a drug or treatment.